Correction to: Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061 (Gastric Cancer, (2021), 24, 6, (1330-1340), 10.1007/s10120-021-01200-w)

Eric Van Cutsem*, Mayur Amonkar, Charles S. Fuchs, Maria Alsina, Mustafa Özgüroğlu, Yung Jue Bang, Hyun Cheol Chung, Kei Muro, Eray Goekkurt, Al B. Benson, Weijing Sun, Zev A. Wainberg, Josephine M. Norquist, Xinqun Chen, Chie Schin Shih, Kohei Shitara

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Correction to: Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061 (Gastric Cancer, (2021), 24, 6, (1330-1340), 10.1007/s10120-021-01200-w)'. Together they form a unique fingerprint.

Medicine & Life Sciences